Silverfin false false 31/03/2026 01/04/2025 31/03/2026 Dr P T Reid 24/02/2012 Dr E S Wilkinson 24/02/2012 12 May 2026 no description of principal activity SC417861 2026-03-31 SC417861 bus:Director1 2026-03-31 SC417861 bus:Director2 2026-03-31 SC417861 2025-03-31 SC417861 core:CurrentFinancialInstruments 2026-03-31 SC417861 core:CurrentFinancialInstruments 2025-03-31 SC417861 core:ShareCapital 2026-03-31 SC417861 core:ShareCapital 2025-03-31 SC417861 core:RetainedEarningsAccumulatedLosses 2026-03-31 SC417861 core:RetainedEarningsAccumulatedLosses 2025-03-31 SC417861 core:PlantMachinery 2025-03-31 SC417861 core:Vehicles 2025-03-31 SC417861 core:FurnitureFittings 2025-03-31 SC417861 core:ComputerEquipment 2025-03-31 SC417861 core:PlantMachinery 2026-03-31 SC417861 core:Vehicles 2026-03-31 SC417861 core:FurnitureFittings 2026-03-31 SC417861 core:ComputerEquipment 2026-03-31 SC417861 bus:OrdinaryShareClass1 2026-03-31 SC417861 2025-04-01 2026-03-31 SC417861 bus:FilletedAccounts 2025-04-01 2026-03-31 SC417861 bus:SmallEntities 2025-04-01 2026-03-31 SC417861 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 SC417861 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 SC417861 bus:Director1 2025-04-01 2026-03-31 SC417861 bus:Director2 2025-04-01 2026-03-31 SC417861 core:PlantMachinery core:TopRangeValue 2025-04-01 2026-03-31 SC417861 core:Vehicles 2025-04-01 2026-03-31 SC417861 core:FurnitureFittings core:TopRangeValue 2025-04-01 2026-03-31 SC417861 core:ComputerEquipment core:TopRangeValue 2025-04-01 2026-03-31 SC417861 2024-04-01 2025-03-31 SC417861 core:PlantMachinery 2025-04-01 2026-03-31 SC417861 core:FurnitureFittings 2025-04-01 2026-03-31 SC417861 core:ComputerEquipment 2025-04-01 2026-03-31 SC417861 bus:OrdinaryShareClass1 2025-04-01 2026-03-31 SC417861 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: SC417861 (Scotland)

# REID WILKINSON MEDICAL LIMITED

### UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH THE REGISTRAR

REID WILKINSON MEDICAL LIMITED

## UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026

Contents

REID WILKINSON MEDICAL LIMITED

## BALANCE SHEET

AS AT 31 MARCH 2026
REID WILKINSON MEDICAL LIMITED

## BALANCE SHEET (continued)

AS AT 31 MARCH 2026

| Note | 2026 |  | 2025
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 | 26,110 |  | 32,797
|  | 26,110 |  | 32,797
Current assets |  |  |  |
Debtors | 4 | 162,701 |  | 160,139
Cash at bank and in hand | 5 | 1,363,076 |  | 1,247,427
|  | 1,525,777 |  | 1,407,566
Creditors: amounts falling due within one year | 6 | ( 96,109) |  | ( 100,439)
Net current assets |  | 1,429,668 |  | 1,307,127
Total assets less current liabilities |  | 1,455,778 |  | 1,339,924
Provision for liabilities | 7 | ( 6,528) |  | ( 8,200)
Net assets |  | 1,449,250 |  | 1,331,724
Capital and reserves |  |  |  |
Called-up share capital | 8 | 10 |  | 10
Profit and loss account |  | 1,449,240 |  | 1,331,714
Total shareholders' funds |  | 1,449,250 |  | 1,331,724

For the financial year ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Reid Wilkinson Medical Limited (registered number: SC417861) were approved and authorised for issue by the Board of Directors on 12 May 2026. They were signed on its behalf by:

Dr P T Reid Director |

REID WILKINSON MEDICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026
REID WILKINSON MEDICAL LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MARCH 2026

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Reid Wilkinson Medical Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in Scotland. The address of the Company's registered office is C/O Johnston Carmichael, 7-11 Melville Street, Edinburgh, EH3 7PE, Scotland, United Kingdom.
The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Turnover

Turnover is recognised at the fair value of the consideration received or receivable for the sale of medical supplies and is shown net of VAT and other sales related taxes.

##### Employee benefits

Short term benefits
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised as an expense when the Company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

##### Tangible fixed assets

Tangible fixed assets are stated at cost, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery | 5 years straight line
Vehicles | 25 % reducing balance
Fixtures and fittings | 5 years straight line
Computer equipment | 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

##### Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Profit and Loss Account as described below.

##### Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities
Basic financial liabilities, including creditors are recognised at transaction price.
Trade Creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

Equity instruments
Equity instruments issued by the Company are recorded at the fair value of cash or other resources received or receivable, net of direct issue costs. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the Company.

##### Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

#### 2. Employees

| 2026 |  | 2025
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including directors | 2 |  | 2

#### 3. Tangible assets

| Plant and machinery |  | Vehicles |  | Fixtures and fittings |  | Computer equipment |  | Total
| £ |  | £ |  | £ |  | £ |  | £
Cost |  |  |  |  |  |  |  |  |
At 01 April 2025 | 3,997 |  | 75,128 |  | 923 |  | 7,555 |  | 87,603
Additions | 0 |  | 0 |  | 0 |  | 2,248 |  | 2,248
At 31 March 2026 | 3,997 |  | 75,128 |  | 923 |  | 9,803 |  | 89,851
Accumulated depreciation |  |  |  |  |  |  |  |  |
At 01 April 2025 | 3,997 |  | 44,089 |  | 923 |  | 5,797 |  | 54,806
Charge for the financial year | 0 |  | 7,760 |  | 0 |  | 1,175 |  | 8,935
At 31 March 2026 | 3,997 |  | 51,849 |  | 923 |  | 6,972 |  | 63,741
Net book value |  |  |  |  |  |  |  |  |
At 31 March 2026 | 0 |  | 23,279 |  | 0 |  | 2,831 |  | 26,110
At 31 March 2025 | 0 |  | 31,039 |  | 0 |  | 1,758 |  | 32,797

#### 4. Debtors

| 2026 |  | 2025
| £ |  | £
Trade debtors | 161,859 |  | 158,294
Other debtors | 842 |  | 1,845
| 162,701 |  | 160,139

#### 5. Cash and cash equivalents

| 2026 |  | 2025
| £ |  | £
Cash at bank and in hand | 1,363,076 |  | 1,247,427

#### 6. Creditors: amounts falling due within one year

| 2026 |  | 2025
| £ |  | £
Taxation and social security | 90,555 |  | 93,591
Other creditors | 5,554 |  | 6,848
| 96,109 |  | 100,439

#### 7. Provision for liabilities

| 2026 |  | 2025
| £ |  | £
Deferred tax | 6,528 |  | 8,200

#### 8. Called-up share capital

| 2026 |  | 2025
| £ |  | £
Allotted, called-up and fully-paid |  |  |
10 Ordinary shares of £ 1.00 each | 10 |  | 10